{"id":105,"date":"2026-03-24T21:45:01","date_gmt":"2026-03-24T21:45:01","guid":{"rendered":"https:\/\/depcell.com\/home\/"},"modified":"2026-09-05T15:48:38","modified_gmt":"2026-09-05T15:48:38","slug":"home","status":"publish","type":"page","link":"https:\/\/depcell.com\/lv\/","title":{"rendered":"Home"},"content":{"rendered":"<div class=\"wp-block-group alignfull ext-hero-section is-style-ext-preset--group--natural-1--section has-background-background-color has-background is-layout-flow wp-block-group-is-layout-flow is-style-ext-preset--group--natural-1--section--1\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--70)\">\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center is-layout-flex wp-container-core-columns-is-layout-d96dcb9d wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h1 class=\"wp-block-heading has-text-align-center ext-animate--on\">Par mums<\/h1>\n\n\n\n<div class=\"wp-block-group ext-animate--on has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group ext-animate--on has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"has-text-align-center ext-animate--on wp-block-paragraph\" style=\"margin-top:1.5rem\">M\u016bsu komanda ir izstr\u0101d\u0101jusi jaunu pieeju visv\u0113rt\u012bg\u0101ko cilmes \u0161\u016bnu ar visgar\u0101kaj\u0101m telom\u0113r\u0101m izdal\u012b\u0161anai, sasniedzot t\u012br\u012bbas l\u012bmeni tuvu 95% neatkar\u012bgi no \u0161\u016bnu avota. Tas nodro\u0161ina skaidru priek\u0161roc\u012bbu sal\u012bdzin\u0101jum\u0101 ar pieej\u0101m, kas balst\u0101s uz dabiski jaun\u0101kiem \u0161\u016bnu avotiem un maz\u0101k v\u0113rt\u012bg\u0101m \u0161\u016bnu popul\u0101cij\u0101m.<\/p>\n\n\n\n<div class=\"wp-block-columns ext-animate--on is-layout-flex wp-container-core-columns-is-layout-e35d3e13 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large ext-animate--on\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-1024x1024.png\" alt=\"\" class=\"wp-image-632\" srcset=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-1024x1024.png 1024w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-300x300.png 300w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-150x150.png 150w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-768x768.png 768w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-1536x1536.png 1536w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap-12x12.png 12w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/bitmap.png 1723w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<figure class=\"wp-block-video ext-animate--on\"><video height=\"1080\" style=\"aspect-ratio: 1920 \/ 1080;\" width=\"1920\" controls src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/05\/Promo_07_voice_music_subtitles-1.mp4\" playsinline><\/video><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"has-text-align-center ext-animate--on wp-block-paragraph\" style=\"margin-top:1.5rem\">Misijas m\u0113r\u0137is ir valid\u0113t un komercializ\u0113t \u0161o tehnolo\u0123iju jau tagad, nodro\u0161inot dro\u0161\u0101kas un pieejam\u0101kas re\u0123enerat\u012bv\u0101s terapijas, kas balst\u012btas uz pa\u0161a pacienta atlas\u012btaj\u0101m \u0161\u016bn\u0101m, ar augstu potenci\u0101lu vesel\u012bgas noveco\u0161anas veicin\u0101\u0161an\u0101 un cit\u0101s n\u0101kotnes medic\u012bnas pielietojuma jom\u0101s.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<figure class=\"wp-block-image aligncenter size-large is-resized ext-animate--on\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/d0f15f1b-4115-4a62-819e-09bba44504fc-kopija-2-1024x683.png\" alt=\"\" class=\"wp-image-210\" style=\"aspect-ratio:1.4992854967554525;width:1268px;height:auto\" srcset=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/d0f15f1b-4115-4a62-819e-09bba44504fc-kopija-2-1024x683.png 1024w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/d0f15f1b-4115-4a62-819e-09bba44504fc-kopija-2-300x200.png 300w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/d0f15f1b-4115-4a62-819e-09bba44504fc-kopija-2-768x512.png 768w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/d0f15f1b-4115-4a62-819e-09bba44504fc-kopija-2-18x12.png 18w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/d0f15f1b-4115-4a62-819e-09bba44504fc-kopija-2.png 1536w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized ext-animate--on\"><a href=\"https:\/\/biophot.lv\/\"><img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"58\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/04.png\" alt=\"\" class=\"wp-image-248\" style=\"aspect-ratio:4.312208138759173;width:244px;height:auto\" srcset=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/04.png 250w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/04-18x4.png 18w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/a><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull ext-hero-section is-style-ext-preset--group--natural-1--section ext-animate--on has-tertiary-background-color has-background has-global-padding is-layout-constrained wp-block-group-is-layout-constrained is-style-ext-preset--group--natural-1--section--2\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--70)\">\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center ext-animate--on is-layout-flex wp-container-core-columns-is-layout-d96dcb9d wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center ext-animate--on is-layout-flow wp-block-column-is-layout-flow\">\n<h1 class=\"wp-block-heading has-text-align-center ext-animate--on\">Sekojiet DEPCELL jaunumiem Facebook vietn\u0113<\/h1>\n<\/div>\n<\/div>\n\n\n\t\t<div class=\"depcell-fb-feed ext-animate--on\" tabindex=\"0\" aria-label=\"Facebook feed carousel\" aria-roledescription=\"carousel\" data-load-url=\"https:\/\/depcell.com\/wp-admin\/admin-ajax.php\" data-load-nonce=\"c5ce8d72c7\" data-after=\"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\" data-edge=\"published_posts\" data-has-more=\"1\" data-autoplay-ms=\"10000\">\n\t\t\t<div class=\"depcell-fb-feed__viewport\">\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide is-active\" data-post-id=\"1043145735552644_122145028382778257\"  aria-hidden=\"false\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122145028382778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/865584539_122145199730778257_6084581201956904829_n.jpg?stp=dst-jpg_p720x720_tt6&#038;_nc_cat=111&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=VTXo06dUE68Q7kNvwG9anW9&#038;_nc_oc=AdpLsdD1EDnuACv2KNNWmBZW_SJ5hvIPakEIrvoUGqRLSw3r9PB3tAPMekaQ_uJtM9s&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQLB_5SCorEOSSATGYh5_WDEbiBoT2LYESodlogTaII7yFWta7yHm3KBQlRa4om1MYYtYXYCPhPAIw&#038;oh=00_AQPAsoOML12ABLwMw46ziRHI4c7VquFC92YHdw9dqihP6Q&#038;oe=6AE69E50\" alt=\"LV | Iztur\u012bg\u0101ki p\u0101rkl\u0101jumi n\u0101kam\u0101s paaudzes \u0161\u016bnu \u0161\u0137iro\u0161anai M\u016bsu jaunais AlCrN\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">October 25, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">LV | Iztur\u012bg\u0101ki p\u0101rkl\u0101jumi n\u0101kam\u0101s paaudzes \u0161\u016bnu \u0161\u0137iro\u0161anai M\u016bsu jaunais AlCrN\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">LV | Iztur\u012bg\u0101ki p\u0101rkl\u0101jumi n\u0101kam\u0101s paaudzes \u0161\u016bnu \u0161\u0137iro\u0161anai\n\nM\u016bsu jaunais AlCrN p\u0101rkl\u0101jumu p\u0113t\u012bjums ir public\u0113ts \u017eurn\u0101l\u0101 Surface &amp; Coatings Technology k\u0101 Journal Pre-proof. Taj\u0101 analiz\u0113ta iepriek\u0161 boj\u0101tu p\u0101rkl\u0101jumu nodilumiztur\u012bba temperat\u016br\u0101 l\u012bdz 800 \u00b0C un noteiktas to darb\u012bbas robe\u017eas.\n\nDEPCELL komandai tas ir viens materi\u0101lzin\u0101tnes solis ce\u013c\u0101 uz n\u0101kam\u0101s paaudzes dielektrofor\u0113zes (DEP) \u0161\u0137iro\u0161anas iek\u0101rt\u0101m. M\u016bsu m\u0113r\u0137is ir uzticama \u0161\u016bnu \u0161\u0137iro\u0161ana liel\u0101k\u0101 m\u0113rog\u0101, lai n\u0101kotn\u0113 apmierin\u0101tu daudz liel\u0101ka pacientu skaita vajadz\u012bbas.\n\n\u0160\u0101d\u0101m iek\u0101rt\u0101m b\u016btiska ir augsta virsmu iztur\u012bba pret koroziju, atk\u0101rtotu mazg\u0101\u0161anu un termisko steriliz\u0101ciju. P\u0113t\u012bjums pal\u012bdz izv\u0113rt\u0113t AlCrN potenci\u0101lu \u0161im virzienam; \u0161\u012bs \u012bpa\u0161\u012bbas, sader\u012bba ar \u0161\u016bn\u0101m un \u0161\u0137iro\u0161anas jauda v\u0113l j\u0101valid\u0113 tie\u0161i DEP iek\u0101rt\u0101s.\n\nEN | More durable coatings for next-generation cell sorting\n\nOur new AlCrN coating study is now online in Surface &amp; Coatings Technology as a Journal Pre-proof. It examines the wear resistance of previously damaged coatings at temperatures up to 800 \u00b0C and maps their operating limits.\n\nFor DEPCELL, this is one materials-science step towards next-generation dielectrophoresis (DEP) sorting equipment. Our goal is reliable cell sorting at a larger scale to meet the needs of many more patients in the future.\n\nSuch equipment requires surfaces with high resistance to corrosion, repeated cleaning and thermal sterilisation. The study helps assess AlCrN\u2019s potential for this direction; these properties, compatibility with cells and sorting throughput still require validation in DEP equipment.\n\n\ud83d\udcc4 Damage-tolerant reliability mapping of AlCrN coatings under high-temperature sliding\nhttps:\/\/doi.org\/10.1016\/j.surfcoat.2026.134075\n\nRakst\u0101 apliecin\u0101ts \/ Acknowledged in the article: BioPhoT, DEPCELL \u2014 OSI_PIP_BioPhoT-2025\/2-0096.\n\n#DEPCELL #BioPhoT #MaterialsScience #CellSorting #MedTech #RTUinnovation #RTU #ScienceToBusiness #DeepTechLatvia #RigaTechnicalUniversity #DeepTech #Innovation<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122137637384778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122137637384778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/810659414_122137637198778257_8245902998653149401_n.jpg?stp=dst-jpg_s960x960_tt6&#038;_nc_cat=111&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=-0WDrHfftX0Q7kNvwG6VpoL&#038;_nc_oc=AdopDPfPDolU8ZqPvNaZDtGfbriHUTagOP1swpxHaYv-9twc10oSGKxApdPqCGb1ttM&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQI9Hv-hjvoFRy8nxcCZCRrHVgYI6B3rBH_c5yLWFWEDA7pR0k7APZmQk2XP03wcHeUxItlylZMfvQ&#038;oh=00_AQPWfDdNwfRCAF7UBWm9Phkya6qwhgPsH84J8Hj8CpC92Q&#038;oe=6AE69DBD\" alt=\"EN DEPCELL\u2019s IP strategy and the path to ATMPs in Latvia On 15 September, J\u0101ni\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">September 15, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">EN DEPCELL\u2019s IP strategy and the path to ATMPs in Latvia On 15 September, J\u0101ni\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">EN\n\nDEPCELL\u2019s IP strategy and the path to ATMPs in Latvia\n\nOn 15 September, J\u0101nis Baroni\u0146\u0161 met with Siim Kinnas and presented DEPCELL\u2019s history, value proposition and development strategy, focusing on Latvia\u2019s path to introducing advanced therapy medicinal products (ATMPs).\n\nSiim shared his perspective on intellectual property (IP) strategy. We discussed international business models and the opportunities a practical, patient-centred regulatory framework could create in Latvia, which our team sees as a particularly promising base for DEPCELL\u2019s development.\n\nA key topic was protection at the application level: treatment-method registration and potential patent protection for inventions related to the technology\u2019s medical uses.\n\nThank you, Siim Kinnas and Intellegra IP, for the valuable meeting and insights!\n\nLV\n\nDEPCELL IP strat\u0113\u0123ija un ce\u013c\u0161 uz ATMP ievie\u0161anu Latvij\u0101\n\n15. septembr\u012b J\u0101nis Baroni\u0146\u0161 tik\u0101s ar Siim Kinnas un iepaz\u012bstin\u0101ja ar DEPCELL v\u0113sturi, v\u0113rt\u012bbas pied\u0101v\u0101jumu un att\u012bst\u012bbas strat\u0113\u0123iju, \u012bpa\u0161i piev\u0113r\u0161oties uzlabot\u0101s terapijas z\u0101\u013cu (ATMP) ievie\u0161anai Latvij\u0101.\n\nSiim dal\u012bj\u0101s redz\u0113jum\u0101 par intelektu\u0101l\u0101 \u012bpa\u0161uma (IP) strat\u0113\u0123iju. P\u0101rrun\u0101j\u0101m \u0101rvalstu biznesa mode\u013cus un iesp\u0113jas, ko Latvij\u0101 var\u0113tu rad\u012bt praktiski piem\u0113rojams, pacientu dro\u0161\u012bb\u0101 balst\u012bts regul\u0113jums. M\u016bsu komanda Latviju redz k\u0101 \u012bpa\u0161i perspekt\u012bvu vidi DEPCELL att\u012bst\u012bbai.\n\nViens no v\u0113rt\u012bg\u0101kajiem sarunas tematiem bija aizsardz\u012bba pielietojuma l\u012bmen\u012b: \u0101rstniec\u012bbas meto\u017eu re\u0123istr\u0101cijas jaut\u0101jumi un ar tehnolo\u0123ijas medic\u012bnisko pielietojumu saist\u012btu izgudrojumu patent\u0113\u0161anas iesp\u0113jas.\n\nPaldies Siim Kinnas un Intellegra IP par v\u0113rt\u012bgo tik\u0161anos un atzi\u0146\u0101m!\n\nIntellegra IP:\n\ud83c\udf10 https:\/\/www.intellegra.ee\/\n\ud83d\udcf7 Instagram: @intellegra_ip\nhttps:\/\/www.instagram.com\/intellegra_ip\n\ud83d\udcbc LinkedIn: https:\/\/www.linkedin.com\/company\/intellegra-ip\/\n\ud83d\udc64 Siim Kinnas: https:\/\/www.linkedin.com\/in\/siim-kinnas\/\n\n#MedTech #DEPCELL #BioPhoT #RigaTechnicalUniversity #StemCellTherapy #RegenerativeMedicine #Innovation #IntellectualProperty #IPStrategy #ATMP<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122136005714778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122136005714778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/794262344_122136005600778257_2951003268915724710_n.jpg?_nc_cat=105&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=BOlyyq3PePwQ7kNvwFDgiAe&#038;_nc_oc=AdrvFPUzrBis3bilmpfzYz09jVBj3sfPA_HNijQDm0Li6lBBnD_QuiwY2eftKG2L-Dk&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQJWW6Ymf1SYI1CgyR5p9bI4olum6c6YjrvcHcIY8JJ9foJEBNJTWmlydUTyhWx7RJfYfWxTnJz7-A&#038;oh=00_AQMiFjpxwzmcK9-BttJR-1C_sGP6hlQKhCr8Uiv5ltOizw&#038;oe=6AE6A5AF\" alt=\"EN Latvia needs an ATMP hospital-exemption framework that protects patients an\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">September 4, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">EN Latvia needs an ATMP hospital-exemption framework that protects patients an\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">EN\nLatvia needs an ATMP hospital-exemption framework that protects patients and works in practice.\n\nDEPCELL is contributing to the discussion on draft Cabinet Regulation 25-TA-368 through a private-sector submission from SIA \u201cCilmes \u0161\u016bnu tehnolo\u0123ijas\u201d and an institutional position submitted by the Latvian Chamber of Commerce and Industry (LTRK).\n\nThe proposals combine a mandatory patient-safety baseline with documented, product-specific risk assessment and proportionate requirements. They also call for equal objective criteria for qualified public and private institutions and a clear distinction between hospital exemption and clinical trials.\n\nThese are proposals under consideration\u2014not adopted rules or a treatment authorisation.\n\nThank you to entrepreneur Uldis B\u0113rzi\u0146\u0161 for the detailed practical input and to LTRK for its support and representation.\n\nPublic summary: https:\/\/depcell.com\/insights\/atmp-regulation-latvia\/\nInvestor access: https:\/\/depcell.com\/investor-portal\/atmp-regulation-work\/\n\nLV\nLatvijai ir vajadz\u012bgs ATMP slimn\u012bcas iz\u0146\u0113muma regul\u0113jums, kas aizsarg\u0101 pacientus un vienlaikus ir praktiski piem\u0113rojams.\n\nDEPCELL iesaist\u0101s diskusij\u0101 par Ministru kabineta noteikumu projektu 25-TA-368 ar SIA \u201cCilmes \u0161\u016bnu tehnolo\u0123ijas\u201d priv\u0101t\u0101 sektora iesniegumu un LTRK iesniegto institucion\u0101lo poz\u012bciju.\n\nPriek\u0161likumi apvieno oblig\u0101tu pacientu dro\u0161\u012bbas minimumu ar dokument\u0113tu, katram produktam atbilsto\u0161u riska nov\u0113rt\u0113jumu un sam\u0113r\u012bg\u0101m pras\u012bb\u0101m. Tie aicina noteikt ar\u012b vien\u0101dus objekt\u012bvus krit\u0113rijus kvalific\u0113t\u0101m publisk\u0101m un priv\u0101t\u0101m iest\u0101d\u0113m un skaidru robe\u017eu starp slimn\u012bcas iz\u0146\u0113mumu un kl\u012bniskajiem p\u0113t\u012bjumiem.\n\nTie ir izskat\u012b\u0161anai iesniegti priek\u0161likumi, nevis pie\u0146emti noteikumi vai \u0101rst\u0113\u0161anas at\u013cauja.\n\nPaldies uz\u0146\u0113m\u0113jam Uldim B\u0113rzi\u0146am par detaliz\u0113to praktisko ieguld\u012bjumu un LTRK par atbalstu un priek\u0161likumu p\u0101rst\u0101v\u012bbu.\n\nPubliskais kopsavilkums: https:\/\/depcell.com\/lv\/insights\/atmp-regulation-latvia\/\nInvestoru piek\u013cuve: https:\/\/depcell.com\/lv\/investor-portal\/atmp-regulation-work\/\n\n#DEPCELL #ATMP #PatientSafety #PacientuDro\u0161\u012bba #HealthInnovation #Vesel\u012bbasInov\u0101cijas #Latvia #Latvija #LTRK<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122135828666778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122135828666778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/794026441_122135831546778257_7527601406843741587_n.jpg?stp=dst-jpg_p720x720_tt6&#038;_nc_cat=103&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=aF_pFS64olsQ7kNvwE1yW1b&#038;_nc_oc=AdpbpWMfr_brZh-XPNVSyLsGu5jyTosWcQokq0saCpovaXBX4OZipnzASE5_eBvurEo&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQJz-FLrnWrDgRqqo_I8Zgof2eez1DIlJL2iy8DQXzzj8d97-7w1OzycQ2T_tIaKKclnJVmrp6fK3Q&#038;oh=00_AQM1-8PMINOjyog7MSnF-1b2-kdo6sxjSBfCDe_XxQcmGQ&#038;oe=6AE6A2AE\" alt=\"No p\u0113tniec\u012bbas l\u012bdz valid\u0101cijai \ud83d\udd2c DEPCELL ir sasniedzis noz\u012bm\u012bgu projekta star\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">September 3, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">No p\u0113tniec\u012bbas l\u012bdz valid\u0101cijai \ud83d\udd2c DEPCELL ir sasniedzis noz\u012bm\u012bgu projekta star\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">No p\u0113tniec\u012bbas l\u012bdz valid\u0101cijai \ud83d\udd2c\n\nDEPCELL ir sasniedzis noz\u012bm\u012bgu projekta starpposmu \u2014 esam izveidoju\u0161i struktur\u0113tu programmu bezmar\u0137ieru dielektrofor\u0113zes pieejas valid\u0113\u0161anai, lai atlas\u012btu augst\u0101kas kvalit\u0101tes mezenhim\u0101lo stromas un cilmes \u0161\u016bnu apak\u0161popul\u0101cijas.\n\nDarbs turpin\u0101s \u010detros galvenajos virzienos: valid\u0101cijas process, MI atbalst\u012bta \u0161\u016bnu anal\u012bze, kvalit\u0101tes pras\u012bb\u0101m atbilsto\u0161a sadarb\u012bbas vide un tehnolo\u0123ijas turpm\u0101k\u0101s ievie\u0161anas pl\u0101no\u0161ana.\n\nDEPCELL pa\u0161laik ir valid\u0101cijas posma p\u0113tniec\u012bbas projekts. M\u016bsu n\u0101kamais uzdevums ir ieg\u016bt atk\u0101rtojamus un l\u0113mumu pie\u0146em\u0161anai izmantojamus pier\u0101d\u012bjumus par tehnolo\u0123ijas veiktsp\u0113ju.\n\n\ud83c\udf10 Publiskais progresa kopsavilkums:\nhttps:\/\/depcell.com\/lv\/insights\/midterm-progress-update\/\n\n\ud83d\udd10 Sl\u0113gt\u0101 starpposma atskaite apstiprin\u0101tiem investoriem:\nhttps:\/\/depcell.com\/lv\/investor-portal\/midterm-report\/\n\n#DEPCELL #BioPhoT #RTU #CilmesS\u016bnas #Regenerat\u012bv\u0101Medic\u012bna #MedTech\n\nFrom research to validation \ud83d\udd2c\n\nDEPCELL has reached an important project milestone. We have established a structured programme to validate a marker-free dielectrophoresis approach for selecting higher-quality mesenchymal stromal and stem cell subpopulations.\n\nWork is progressing across four key areas: the validation pathway, AI-assisted cell analysis, a quality-aligned partner environment, and planning for the technology\u2019s future translation.\n\nDEPCELL remains a validation-stage research project. Our next priority is to generate repeatable, decision-ready evidence about the platform\u2019s performance.\n\n\ud83c\udf10 Read the public progress summary:\nhttps:\/\/depcell.com\/insights\/midterm-progress-update\/\n\n\ud83d\udd10 Approved investors can access the protected mid-term report:\nhttps:\/\/depcell.com\/investor-portal\/midterm-report\/\n\n#DEPCELL #BioPhoT #RTU #StemCellResearch #RegenerativeMedicine #MedTech<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122128778858778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122128778858778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/external-bru2-1.xx.fbcdn.net\/emg1\/v\/t13\/7009129066072751627?url=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fkfson--OsOQ%2Fmaxresdefault.jpg%3Fsqp%3D-oaymwEmCIAKENAF8quKqQMa8AEB-AH-CYAC0AWKAgwIABABGGUgVChOMA8%3D%26rs%3DAOn4CLCXIKfhGCuqRpy4upT-HdlfadvINA&#038;fb_obo=1&#038;utld=ytimg.com&#038;_nc_sid=50234c&#038;_nc_ht=external-bru2-1.xx.fbcdn.net&#038;stp=dst-emg0_q75_s1280x720_tt6&#038;ccb=18-1&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;edm=APyxFHYEAAAA&#038;_nc_zt=3&#038;_nc_tpa=Q5bMBQIYU_PeouyJUM_RuFLkzo7W3V0j97ADnWaXW90Al88ADzjB-nFdUcOqHHcP6idGp442WK6lk26dYw&#038;oh=06_Q3_EAexm1JzyJdyBIwn1LZtUrzNYxb3VxP0v8l_2lQxLgCcV&#038;oe=6AE2B017\" alt=\"https:\/\/www.youtube.com\/watch?v=kfson--OsOQ\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">July 27, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">https:\/\/www.youtube.com\/watch?v=kfson&#8211;OsOQ<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">https:\/\/www.youtube.com\/watch?v=kfson&#8211;OsOQ<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122119170854778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122119170854778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/721517416_122119170734778257_85940840679672950_n.jpg?stp=cp1_dst-jpg_s960x960_tt6&#038;_nc_cat=105&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=usvb_rc-gBMQ7kNvwE4sKRs&#038;_nc_oc=AdpHHNI5dJIC5lW33_bVTbaUKrV85dllPaVMWXbFc5eTBD-ggdYBL-XwZRvY3jh9yHU&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQJO3F03qdZSHsLNhVMcQXCH7_9rq4_mTdaExWvd1rcaEg-5OiMIlWjKlT87Fb-2fZWpYi9E1xzzOQ&#038;oh=00_AQPf9qgMFJTfefluEYqSpq5nJ7KCtcTp6REk-GJwBCGVuw&#038;oe=6AE6B58B\" alt=\"Hello Tomorrow Amsterdam\u0101 aizvad\u012bta ar\u012b otr\u0101 BioPhoT prezent\u0101ciju sesija \u2013 kas\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">June 12, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">Hello Tomorrow Amsterdam\u0101 aizvad\u012bta ar\u012b otr\u0101 BioPhoT prezent\u0101ciju sesija \u2013 kas\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">Hello Tomorrow Amsterdam\u0101 aizvad\u012bta ar\u012b otr\u0101 BioPhoT prezent\u0101ciju sesija \u2013 kas v\u0113lreiz apliecin\u0101ja Latvijas dzi\u013co tehnolo\u0123iju potenci\u0101lu starptautisk\u0101 l\u012bmen\u012b \ud83d\udc4c \n\n\u0160aj\u0101 sesij\u0101 iev\u0113rojamu uzman\u012bbu no investoriem un nozares profesion\u0101\u013ciem piesaist\u012bja Latvij\u0101 topo\u0161ie biomedic\u012bnas un integr\u0113to tehnolo\u0123iju projekti.\n\n\ud83d\udc4f Apmekl\u0113t\u0101ju un partneru atsauksmes iez\u012bm\u0113 vienotu tendenci \u2013 Latvijas zin\u0101tnieku un jaunuz\u0146\u0113mumu pied\u0101v\u0101tie risin\u0101jumi ir ne tikai inovat\u012bvi, bet ar\u012b skaidri struktur\u0113ti un ar sp\u0113c\u012bgu pielietojuma potenci\u0101lu.\n\nhashtag#BioPhoT hashtag#DeepTech hashtag#HelloTomorrow\n\nShow translation<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122118775574778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/reel\/865783059357762\/\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t15.5256-10\/720623608_977413655156034_4094027287677189637_n.jpg?_nc_cat=110&#038;ccb=1-7&#038;_nc_sid=5fad0e&#038;_nc_ohc=vp4OehVdAN8Q7kNvwEq1Ugq&#038;_nc_oc=AdoA5WBRrmee4Lzj9XXa4F-2ho7pYAIGcr5TsActNC5udp_8lQ264BWrTDKNilg_O8k&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQJGAkBVQAne-sjBU4ANlPpY5jQd6u3bbqic_E-yk5buTiGOkFY8DN5INjhpYLzIPVRqp3BesPHvyQ&#038;oh=00_AQPuFshhwcjx6UBqyVUqojquoK49bqy3cSOtV0zdZZtkzA&#038;oe=6AE6BBC1\" alt=\"he 2026 Hello Tomorrow Summit - Day 1 - meeting with investors. First meeting \u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">June 10, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">he 2026 Hello Tomorrow Summit &#8211; Day 1 &#8211; meeting with investors. First meeting \u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">he 2026 Hello Tomorrow Summit &#8211; Day 1 &#8211; meeting with investors.\nFirst meeting with potential investors. \nThere is strong interest in DepCell. They said they would call and speak with us.\nUldis Berzins\n#MedTech #DEPCELL #BioPhoT #RigaTechnicalUniversity #StemCellTherapy #RegenerativeMedicine #Innovation<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122118775382778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122118775382778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/719674184_122118775022778257_7213907907528786387_n.jpg?stp=dst-jpg_p720x720_tt6&#038;_nc_cat=110&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=iFMNUIzO9boQ7kNvwGS7io3&#038;_nc_oc=Ado2IFk2eJNGZVLrOFF3HEuc_UpuLf0y634vaHMkei8zVhNfFw6BjltIjagIbcx-K6A&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQKb-oRsxxjnQrpNDZ9T0yo4l0-itDNZV-_VCWLSWhlox8SEzowDTO_MJo6EqAAkboLRRAoxI0rYTg&#038;oh=00_AQMsLiHh_uyyM-F1jL3EnAFPyxUnB7Sr97mraWA5dvijYQ&#038;oe=6AE6BC29\" alt=\"The 2026 Hello Tomorrow Summit - Day 1 - meeting with investors. First meeting\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">June 10, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">The 2026 Hello Tomorrow Summit &#8211; Day 1 &#8211; meeting with investors. First meeting\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">The 2026 Hello Tomorrow Summit &#8211; Day 1 &#8211; meeting with investors.\nFirst meeting with potential investors. \nThere is strong interest in DepCell. They said they would call and speak with us.\nUldis Berzins\n\n#MedTech #DEPCELL #BioPhoT #RigaTechnicalUniversity #StemCellTherapy #RegenerativeMedicine #Innovation<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122118604898778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122118604898778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/720647874_122118604868778257_8653285520649926212_n.jpg?stp=cp1_dst-jpg_p720x720_tt6&#038;_nc_cat=104&#038;ccb=1-7&#038;_nc_sid=833d8c&#038;_nc_ohc=qqpAdhWhtDIQ7kNvwFsNnDa&#038;_nc_oc=Adr322ttCUWQDnwbg17nRtbR_TyAVfu3YjwC9TVVgIC3-cJU7IR2tZVKcdFBuHyZCJw&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQJm-xmQGiSjR_vh8K9uK1c1bYhqZB7DDdih8idSdZmN7Qs_WnGYjt9QQczhIM9pbrZF_shWngSEww&#038;oh=00_AQOG-9unAt14HYvIVEEoS-jI4zEnNGJf-yEGiIk3b5ZOCQ&#038;oe=6AE6D270\" alt=\"https:\/\/biophot.lovable.app\/ The scalability and efficacy of advanced stem cel\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">June 9, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">https:\/\/biophot.lovable.app\/ The scalability and efficacy of advanced stem cel\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">https:\/\/biophot.lovable.app\/\n\nThe scalability and efficacy of advanced stem cell therapies are often bottlenecked by the high cost and complexity of cell sorting, as current methods frequently rely on chemical labeling that can alter cell properties or compromise quality. The DEPCELL project addresses this limitation by validating a label-free sorting platform for live mesenchymal stem cells utilizing dielectrophoresis. The technology correlates electric-field separation parameters with critical cell quality indicators such as telomere status and replicative potential. Developed by RTU, this platform is being validated under Good Manufacturing Practice compliant conditions to support immediate hospital applications, while the team concurrently integrates an AI-assisted quality control workstation to enable real-time, label-free cell analysis. By offering a more precise, standardized, and affordable workflow for processing adipose-derived stem cells, the project enhances the reproducibility of future cell therapies, establishing a foundation for treating complex conditions such as psoriasis, rheumatoid arthritis, and Crohn\u2019s disease to make advanced regenerative medicine safer and more accessible.<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide\" data-post-id=\"1043145735552644_122116316210778257\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<a class=\"depcell-fb-feed__image-link\" href=\"https:\/\/www.facebook.com\/122096358596778257\/posts\/122116316210778257\" target=\"_blank\" rel=\"noopener noreferrer\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"depcell-fb-feed__image\" src=\"https:\/\/scontent-bru2-1.xx.fbcdn.net\/v\/t39.30808-6\/708979517_122116316084778257_5860860975363370205_n.jpg?stp=dst-jpg_s720x720_tt6&#038;_nc_cat=101&#038;ccb=1-7&#038;_nc_sid=127cfc&#038;_nc_ohc=7nHAbMgjRRQQ7kNvwFQYgaa&#038;_nc_oc=Adq0Y2BZKwmMyvwCCdP2Qnbdm7utz232BwNn_p-sHbHYlHd27nPWAHzr-nKJPc0qJMQ&#038;_nc_zt=23&#038;_nc_ht=scontent-bru2-1.xx&#038;edm=APyxFHYEAAAA&#038;_nc_gid=IC-etzRSbTsjogXFLGF8KA&#038;_nc_tpa=Q5bMBQL-vsOcpNbXCjbXHyZNucgXXX_jThTT6LEnTvQ1kZj5gVA2287YsDkjqE97qgQZU-BYTfYGJIFDFQ&#038;oh=00_AQP9kQtTdQfXBLPC_pPSbtaAdgKEfgvaTVA9pP0IuI-ZsQ&#038;oe=6AE6C775\" alt=\"DEPCELL aicina \u0101rstus un vesel\u012bbas apr\u016bpes ekspertus aizpild\u012bt K-A-I-S-P anket\u2026\" loading=\"lazy\" draggable=\"false\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<div class=\"depcell-fb-feed__body\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"depcell-fb-feed__date\">May 27, 2026<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"depcell-fb-feed__title\">DEPCELL aicina \u0101rstus un vesel\u012bbas apr\u016bpes ekspertus aizpild\u012bt K-A-I-S-P anket\u2026<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-shell\">\n\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text-scroll\" tabindex=\"0\" aria-label=\"Pilns Facebook ieraksta teksts\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"depcell-fb-feed__text\">DEPCELL aicina \u0101rstus un vesel\u012bbas apr\u016bpes ekspertus aizpild\u012bt K-A-I-S-P anketu par \u0101rstu gatav\u012bbu regul\u0113tai iz\u0146\u0113muma jaunieviest\u0101s terapijas z\u0101\u013cu ievie\u0161anai Latvij\u0101.\n\nAnketa ir da\u013ca no Uldis Berzins doktora darba p\u0113t\u012bjuma par ATMP-HE ievie\u0161anas gatav\u012bbu, \u0161\u0137\u0113r\u0161\u013ciem, risin\u0101jumiem un krit\u0113riju noz\u012bm\u012bgumu Latvij\u0101.\n\nAizpild\u012b\u0161ana aiz\u0146em aptuveni 12\u201315 min\u016btes.\nRezult\u0101ti tiks analiz\u0113ti tikai apkopot\u0101 veid\u0101.\nL\u016bdzu, anket\u0101 nenor\u0101diet pacientu datus vai citu identific\u0113jamu pacienta inform\u0101ciju.\n\nAizpild\u012bt anketu:\nhttps:\/\/depcell.com\/medical-doctors-and-experts-portal\/\n\nATMP-HE = Advanced Therapy Medicinal Products \u2013 Hospital Exemption.\n\nPaldies par profesion\u0101lu ieguld\u012bjumu regul\u0113tu \u0161\u016bnu terapiju ievie\u0161anas diskusij\u0101 Latvij\u0101.\n\n#DeepTechAtelier2026 #DTA26 #DeepTech #MedTech #DEPCELL #BioPhoT #RigaTechnicalUniversity #StemCellTherapy #RegenerativeMedicine #Innovation<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<article class=\"depcell-fb-feed__slide depcell-fb-feed__slide--load-more\" data-load-more-slide=\"1\" hidden aria-hidden=\"true\">\n\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__load-more-button\">\n\t\t\t\t\t\t\t<span class=\"depcell-fb-feed__load-more-title\">Iel\u0101d\u0113t n\u0101kamos 10 Facebook ierakstus<\/span>\n\t\t\t\t\t\t\t<span class=\"depcell-fb-feed__load-more-text\">Nospied \u0161eit, lai pievienotu n\u0101kamo ierakstu komplektu \u0161ai rindai.<\/span>\n\t\t\t\t\t\t<\/button>\n\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"depcell-fb-feed__dots\" role=\"tablist\" aria-label=\"Facebook post navigation\">\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot is-active\" data-index=\"0\" aria-label=\"Go to post 1\" aria-selected=\"true\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"1\" aria-label=\"Go to post 2\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"2\" aria-label=\"Go to post 3\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"3\" aria-label=\"Go to post 4\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"4\" aria-label=\"Go to post 5\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"5\" aria-label=\"Go to post 6\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"6\" aria-label=\"Go to post 7\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"7\" aria-label=\"Go to post 8\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"8\" aria-label=\"Go to post 9\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot\" data-index=\"9\" aria-label=\"Go to post 10\" aria-selected=\"false\"><\/button>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<button type=\"button\" class=\"depcell-fb-feed__dot depcell-fb-feed__dot--load-more\" data-index=\"10\" aria-label=\"Load next 10 Facebook posts\" aria-selected=\"false\">+<\/button>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div>\n\n\n\n<div class=\"wp-block-group alignfull ext-hero-section is-style-ext-preset--group--natural-1--section ext-animate--on has-tertiary-background-color has-background has-global-padding is-layout-constrained wp-block-group-is-layout-constrained is-style-ext-preset--group--natural-1--section--3\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--70)\">\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center ext-animate--on is-layout-flex wp-container-core-columns-is-layout-d96dcb9d wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center ext-animate--on is-layout-flow wp-block-column-is-layout-flow\">\n<h1 class=\"wp-block-heading ext-animate--on\">Cilmes \u0161\u016bnu inov\u0101ciju virz\u012bt\u0101jsp\u0113ks Latvij\u0101<\/h1>\n\n\n\n<p class=\"ext-animate--on wp-block-paragraph\" style=\"margin-top:1.5rem\">Iepaz\u012bstiet inovat\u012bvus p\u0113t\u012bjumus un sadarb\u012bbas iniciat\u012bvas, kas veicina pieejam\u0101ku cilmes \u0161\u016bnu terapiju, vied\u0101ku \u0161\u016bnu \u0161\u0137iro\u0161anu un medic\u012bnas zin\u0101tnes att\u012bst\u012bbu Latvij\u0101.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center ext-animate--on is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large is-style-ext-preset--image--natural-1--image-1--content-left ext-animate--on is-style-ext-preset--image--natural-1--image-1--content-left--4\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31-1024x1024.png\" alt=\"\" class=\"wp-image-220\" style=\"aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31-1024x1024.png 1024w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31-300x300.png 300w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31-150x150.png 150w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31-768x768.png 768w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31-12x12.png 12w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/GPT_31.png 1254w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-ext-preset--group--natural-1--section has-background-background-color has-background has-global-padding is-layout-constrained wp-block-group-is-layout-constrained is-style-ext-preset--group--natural-1--section--5\" id=\"about\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--70);padding-bottom:var(--wp--preset--spacing--70)\">\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center is-layout-flex wp-container-core-columns-is-layout-d96dcb9d wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-style-ext-preset--image--natural-1--image-1--content-right ext-animate--on is-style-ext-preset--image--natural-1--image-1--content-right--6\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-2026.-g.-25.-marts-22_56_13.png\" alt=\"\" class=\"wp-image-179\" style=\"aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-2026.-g.-25.-marts-22_56_13.png 1024w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-2026.-g.-25.-marts-22_56_13-300x300.png 300w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-2026.-g.-25.-marts-22_56_13-150x150.png 150w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-2026.-g.-25.-marts-22_56_13-768x768.png 768w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-2026.-g.-25.-marts-22_56_13-12x12.png 12w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<h2 class=\"wp-block-heading ext-animate--on\">P\u0113tniec\u012bbas un cilmes \u0161\u016bnu inov\u0101ciju savieno\u0161ana<\/h2>\n\n\n\n<p class=\"ext-animate--on wp-block-paragraph\" style=\"margin-top:1.5rem\">DEPCELL m\u0113r\u0137is ir valid\u0113t uz dielektrofor\u0113zi balst\u012btu sist\u0113mu cilmes \u0161\u016bnu popul\u0101ciju izdal\u012b\u0161anai ar paaugstin\u0101tu terapeitisko potenci\u0101lu, lai veicin\u0101tu efekt\u012bv\u0101ku t\u0101du autoim\u016bnu slim\u012bbu \u0101rst\u0113\u0161anu, kuras nav pietiekami kontrol\u0113jamas ar konvencion\u0101lo terapiju. Projekts \u012bpa\u0161i koncentr\u0113jas uz psori\u0101zi, Krona slim\u012bbu, 1. tipa cukura diab\u0113tu un reimato\u012bdo artr\u012btu.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull ext-hero-section is-style-ext-preset--group--natural-1--section ext-animate--on has-tertiary-background-color has-background is-layout-flow wp-block-group-is-layout-flow is-style-ext-preset--group--natural-1--section--7\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--70)\">\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center ext-animate--on is-layout-flex wp-container-core-columns-is-layout-d96dcb9d wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center ext-animate--on is-layout-flow wp-block-column-is-layout-flow\">\n<h1 class=\"wp-block-heading has-text-align-center ext-animate--on\">Partneri<\/h1>\n<\/div>\n<\/div>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized ext-animate--on\"><img loading=\"lazy\" decoding=\"async\" width=\"878\" height=\"857\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/03.png\" alt=\"\" class=\"wp-image-236\" style=\"aspect-ratio:1;object-fit:contain;width:1268px\" srcset=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/03.png 878w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/03-300x293.png 300w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/03-768x750.png 768w, https:\/\/depcell.com\/wp-content\/uploads\/2026\/04\/03-12x12.png 12w\" sizes=\"auto, (max-width: 878px) 100vw, 878px\" \/><\/figure>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center ext-animate--on\" id=\"contacts\">Kontakti<\/h2>\n\n\n\n<div class=\"wp-block-columns ext-animate--on is-layout-flex wp-container-core-columns-is-layout-e35d3e13 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<p class=\"has-text-align-center ext-animate--on wp-block-paragraph\">Paula Valdena iela 7<br>Dabaszin\u0101t\u0146u un tehnolo\u0123iju fakult\u0101te<br><br>Fizikas un materi\u0101lzin\u0101tnes instit\u016bts<br><br>Telpa 323<br><br>info@depcell.com<br>www.depcell.com<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<iframe src=\"https:\/\/www.google.com\/maps\/embed?pb=!1m18!1m12!1m3!1d3272.146275315586!2d24.0758543131568!3d56.95283089881785!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x46eecfe108121d51%3A0x8313f8eadaf55bff!2sPaula%20Valdena%20iela%207%2C%20Kurzemes%20rajons%2C%20R%C4%ABga%2C%20LV-1048!5e1!3m2!1slv!2slv!4v1778609998027!5m2!1slv!2slv\" width=\"600\" height=\"450\" style=\"border:0;display:block;width:100%;max-width:100%;\" allowfullscreen=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\"><\/iframe>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>About Our team has created a new pathway for isolating the most valuable stem cells with the longest telomeres, reaching purity levels close to 95% regardless of source. This gives a clear advantage over approaches that rely on naturally younger cell sources and lower-value cell populations. Our mission is to validate and commercialize this technology [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"no-title","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-105","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/comments?post=105"}],"version-history":[{"count":48,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/105\/revisions"}],"predecessor-version":[{"id":719,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/105\/revisions\/719"}],"wp:attachment":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/media?parent=105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}